TET1 was found to bind directly to the promoter of PPARα and increase its hydroxymethylation level, ultimately inhibiting the progression of non-alcoholic fatty liver disease.108. This evidence concerns the gene TET1 and metabolic dysfunction-associated steatotic liver disease.